Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 4.6B | 5.3B | 5.9B | 5.1B |
Cost of revenue | 2.4B | 4.1B | 4.5B | 3.9B |
Gross profit | 2.1B | 1.3B | 1.4B | 1.1B |
Operating expense | ||||
Research & development | 613.2M | 642.9M | 512.7M | 647.4M |
Selling general and admin | 420.3M | 365.8M | 274.6M | 313.0M |
Other operating expenses | — | — | — | — |
Operating income | 1.1B | 250.8M | 597.5M | 175.2M |
Non operating interest income | ||||
Income | 46.9M | 52.6M | 56.9M | 48.4M |
Expense | 396K | 438K | 1.8M | 4.4M |
Other income expense | — | — | — | — |
Pretax income | 1.3B | 724.2M | 321.4M | 843.7M |
Tax provision | 376.7M | 238.1M | 88.1M | 319.1M |
Net income | 926.0M | 486.1M | 233.3M | 524.6M |
Basic EPS | 2.0 | — | 0.6 | 1.3 |
Diluted EPS | 2.0 | — | 0.6 | 1.3 |
Basic average shares | 470.1M | — | 395.5M | 394.4M |
Diluted average shares | 474.9M | — | 424.2M | 409.8M |
EBITDA | 1.4B | 814.0M | 317.7M | 917.5M |
Net income from continuing op. | 1.3B | 724.2M | — | 843.7M |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |